If you take the position that FXR is the most “validated” NASH target, at least for early-stage disease, then you ought to include ENTA on your list. Please see #msg-128917063 for related info.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.